Product logins

Find logins to all Clarivate products below.


ENT Devices | Market Insights | Asia Pacific (Supplemental) | 2022

The COVID-19 pandemic will have a significant impact on ENT procedure volumes as growing developments in alternative treatment such as antibiotics and the continued effort of various associations to promote alternatives to surgery will affect the rebound of procedures. However, as the situation around COVID-19 stabilizes, there will be increased adoption of innovative and premium-priced products, such as flexiblescopes, RF handpieces, and powered instruments. As a result, the Asia Pacific market for ENT devices will grow at a relatively modest pace following the impact of the pandemic.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for ENT devices in the Asia Pacific region across an 11-year period.

Related Medtech Insights Reports

Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Trauma Devices – Market Insights – Asia Pacific
The Asia Pacific trauma device market is experiencing steady growth driven by a rising incidence of fractures, an aging population, and increasing rates of road traffic accidents, particularly in…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Asia Pacific
The Asia Pacific TEO device market will experience steady growth over the forecast period, driven by rising cancer incidence, increasing preference for minimally invasive procedures, and clinical…
Report
Dialysis Access Treatment Devices – Market Insights – Asia Pacific
The Asia Pacific dialysis access treatment device market will grow modestly through 2034, driven by the increasing patient population requiring dialysis care and the anticipated launch of devices…